Articles in "IIBR"
Israel Expands 2nd Phase of COVID-19 Vaccine Trials in Georgia
A shipment of 1,125 BriLife vaccine vials was sent over the weekend from Israel to Georgia, where the second phase of clinical trials for ...
Israel Commences Human Trials with COVID-19 Vaccine
Hadassah Hospital in Jerusalem and Sheba Hospital in Tel Aviv commenced on Sunday with human trials with the Coronavirus (COVID-19) ...
Israel Announces Entry into Critical Phase of COVID-19 Vaccine Development
The Ministry of Defense, the Israel Institute for Biological Research (IIBR) and the Ministry of Health announced on Sunday the approval ...
‘Brilife:’ Israel Unveils Name of COVID-19 Vaccine
Minister of Defense Benny Gantz on Monday toured the Israel Institute for Biological Research (IIBR) and was updated on the advancements in ...
Israeli Scientists Map Coronavirus Protein Production Profile, Can Lead to Better Diagnostics and Treatment
Israeli scientists at the Weizmann Institute of Science and the Israel Institute for Biological Research (IIBR) in Ness Ziona have mapped ...
Israel: We Can Produce 15 Million COVID-19 Vaccines
Israel's Institute for Biological Research (IIBR) can produce 15 million Coronavirus (COVID-19) vaccine doses for Israelis after it ...
‘We Have the Product in Hand:’ Israel Will Begin Human Trials with COVID-19 Vaccine in October
The Israel Institute for Biological Research (IIBR) in Ness Ziona has made further progress toward a Coronavirus (COVID-19) vaccine and ...
Israel Reports Progress in Quest for COVID-19 Vaccine
The Israel Institute for Biological Research (IIBR) in Ness Ziona has reported that it has made further progress toward a Coronavirus ...
Hope? Israeli Research Finds Medication for Gaucher’s Disease Effective in Fighting Coronavirus
Derivatives of two drugs designed to treat Gaucher's disease have been shown to be effective against Coronavirus (COVID-19) and may be ...
Israel Take Another Step Towards Development of Coronavirus Cure
The Israel Institute for Biological Research (IIBR) in Ness Ziona has completed the patent registration for eight Coronavirus (COVID-19) ...
